Exelixis shareholders approve 2017 equity plan amendment, adding 2M shares

EXELIXIS, INC.

Stockholders approved amendment to 2017 Plan, adding 2,000,000 shares to the share reserve.
Full Value Awards granted on or after May 26, 2026, will count as 1 share per share issued (previously 2 for 1).
All 11 director nominees elected; Ernst & Young ratified as auditor; say-on-pay approved.
Amended plan effective immediately upon stockholder approval at May 26, 2026 annual meeting.

item 5.02 item 5.07 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0000939767-26-000074
form_type: 8-K
ticker: EXEL
cik: 0000939767
company_name: EXELIXIS, INC.
filed_at: 2026-05-29T20:05:57+00:00
discovered_at: 2026-05-29T20:08:00.205089+00:00
generated_at: 2026-05-29T20:08:24.527752+00:00
sec_items: ["5.02", "5.07", "9.01"]
event_type: other_material
sentiment: neutral
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0000939767-26-000074
json_url: https://secwatch.observer/filing/0000939767-26-000074.json
markdown_url: https://secwatch.observer/filing/0000939767-26-000074.md
text_url: https://secwatch.observer/filing/0000939767-26-000074.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/939767/000093976726000074/0000939767-26-000074-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/939767/000093976726000074/exel-20260526.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Comparable filings

TNYA

Tenaya shareholders approve amended equity plan adding 6.5M shares, elect directors

Tenaya Therapeutics, Inc. May 29, 2026, 5:04 PM ET other_material Items 5.02, 5.07, 9.01

same SEC item: 5.02, 5.07, 9.01 same event type: other_material similar materiality

Filing page SEC filing

SYRE

Spyre Therapeutics stockholders approve amended ESPP; director Peter Harwin resigns

Spyre Therapeutics, Inc. May 29, 2026, 4:45 PM ET other_material Items 5.02, 5.07, 9.01

same SEC item: 5.02, 5.07, 9.01 same event type: other_material similar materiality

Filing page SEC filing

EVC

Entravision stockholders approve 6M share increase in equity plan at annual meeting

ENTRAVISION COMMUNICATIONS CORP May 29, 2026, 4:30 PM ET other_material Items 5.02, 5.07, 9.01

same SEC item: 5.02, 5.07, 9.01 same event type: other_material similar materiality

Filing page SEC filing

EFC

Ellington Financial stockholders approve 2026 Equity Incentive Plan and reelect directors

Ellington Financial Inc. May 29, 2026, 4:13 PM ET other_material Items 5.02, 5.07, 9.01

same SEC item: 5.02, 5.07, 9.01 same event type: other_material similar materiality

Filing page SEC filing

RDAC

Shareholders approve SPAC extension to Oct 15, 2027; ~1.9M shares redeemed

Rising Dragon Acquisition Corp. June 1, 2026, 6:08 AM ET other_material Items 1.01, 5.03, 5.07, 8.01, 9.01

same SEC item: 5.07, 9.01 same event type: other_material similar materiality

Filing page SEC filing

AVX

Avax One shareholders approve reverse stock split (1:2 to 1:12) at annual meeting

AVAX ONE TECHNOLOGY LTD. May 29, 2026, 4:30 PM ET other_material Items 5.07, 9.01

same SEC item: 5.07, 9.01 same event type: other_material similar materiality

Filing page SEC filing

INDI

Indie Semiconductor shareholders approve 17M share increase for equity incentive plan

indie Semiconductor, Inc. May 29, 2026, 4:21 PM ET other_material Items 5.02, 5.07

same SEC item: 5.02, 5.07 same event type: other_material similar materiality

Filing page SEC filing

WORLDS INC

Worlds Inc. changes name to Gemaxel Inc., effective March 26, 2026

WORLDS INC June 1, 2026, 2:59 PM ET other_material Items 5.03, 9.01

same SEC item: 9.01 same event type: other_material similar materiality

Filing page SEC filing

Source: SEC EDGAR

accession 0000939767-26-000074

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.